dbpr110
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2017 (NCT02617615)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatitis C virusUltraviolet filter
Hepatitis C virus ultraviolet filter
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dbpr110
- mb-110
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02617615 | Phase 1 | Dec 1, 2017 | Government of Taiwan, Microbio Co Ltd |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Taiwan | Government | 1 | 0 | 1 | 2017 |
| Microbio Co Ltd | For profit | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1